Literature DB >> 8433555

Human 92 kDa type IV collagenase: functional analysis of fibronectin and carboxyl-end domains.

A Y Strongin1, I E Collier, P A Krasnov, L T Genrich, B L Marmer, G I Goldberg.   

Abstract

Two closely related secreted metalloproteases 72 and 92 kDa type IV collagenases (72- and 92T4Cl) consist of several structural domains, the functions of which are poorly understood. Both metalloproteases can bind to gelatin as well as form complexes with specific inhibitors in the proenzyme form. The biologic role of the proenzyme-inhibitor complex formation remained unclear. Here we summarize results demonstrating that the fibronectin-like domain of 92T4Cl mediates gelatin binding of the proenzyme, while the hemopexin like carboxy-terminal domain is essential for the complex formation of the proenzyme with TIMP. The formation of a 92T4Cl proenzyme complex with TIMP prevents dimerization, formation of the novel complex with ClI proenzyme, and activation of the 92T4Cl by stromelysin. Conversely, formation of the covalent 92T4Cl homodimer excludes the formation of a proenzyme-TIMP complex, thus allowing this form of enzyme to enter into the proteolytic cascade of activation. Both components of the 92T4Cl-ClI complex can be activated in a fashion similar to that of free enzymes, yielding a complex active against both gelatin and fibrillar collagen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8433555     DOI: 10.1038/ki.1993.26

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts.

Authors:  A Y Lee; K T Akers; M Collier; L Li; A Z Eisen; J L Seltzer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

2.  Matrix metalloprotease-3 and tissue inhibitor of metalloprotease-1 mRNA and protein levels are altered in response to traumatic skeletal muscle injury.

Authors:  Maria L Urso; Eric R Szelenyi; Gordon L Warren; Brian R Barnes
Journal:  Eur J Appl Physiol       Date:  2010-03-27       Impact factor: 3.078

3.  Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma.

Authors:  G Sehgal; J Hua; E J Bernhard; I Sehgal; T C Thompson; R J Muschel
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 4.  Matrix metalloproteinases. Novel targets for directed cancer therapy.

Authors:  A E Yu; R E Hewitt; E W Connor; W G Stetler-Stevenson
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

Review 5.  Computational sequence analysis of the tissue inhibitor of metalloproteinase family.

Authors:  D A Douglas; Y E Shi; Q A Sang
Journal:  J Protein Chem       Date:  1997-05

6.  Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway.

Authors:  G S Makowski; M L Ramsby
Journal:  Inflammation       Date:  1998-06       Impact factor: 4.092

7.  Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production.

Authors:  Hitesh S Deshmukh; Anne McLachlan; Jeffrey J Atkinson; William D Hardie; Thomas R Korfhagen; Maggie Dietsch; Yang Liu; Peter Y P Di; Scott C Wesselkamper; Michael T Borchers; George D Leikauf
Journal:  Am J Respir Crit Care Med       Date:  2009-08-06       Impact factor: 21.405

8.  Binding of pro-matrix metalloproteinase 9 by Fusobacterium nucleatum subsp. nucleatum as a mechanism to promote the invasion of a reconstituted basement membrane.

Authors:  Renée Gendron; Pascale Plamondon; Daniel Grenier
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Binding of gelatinases A and B to type-I collagen and other matrix components.

Authors:  J A Allan; A J Docherty; P J Barker; N S Huskisson; J J Reynolds; G Murphy
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

10.  MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties.

Authors:  Qing Sun; Christopher R Weber; Anjum Sohail; M Margarida Bernardo; Marta Toth; Huiren Zhao; Jerrold R Turner; Rafael Fridman
Journal:  J Biol Chem       Date:  2007-05-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.